Navigation Links
Eric J. Topol, M.D. presented with 2011 TCT Career Achievement Award
Date:11/9/2011

SAN FRANCISCO NOVEMBER 9, 2011 Eric J. Topol, MD, a world-renowned cardiologist and physician-scientist, was presented the 2011 TCT Career Achievement Award in a ceremony held today during the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). The award is given each year to a pioneer in the field of interventional cardiovascular medicine.

One of the leading cardiologists in the United States, Dr. Topol spearheaded the discovery of multiple genes which increase a person's risk of heart attacks and pioneered the development of critical heart care therapies now used in daily practice therapies such as clot busters, anti-platelet agents and angioplasty devices. He has led more than 15 international, multi-center research trials involving 40 countries and more than 200,000 patients. He is also a leader in the movement to modernize medical treatment through wireless digital innovative technologies.

TCT Directors, Martin B. Leon, MD and Gregg W. Stone, MD jointly presented the award, which recognizes pioneering work in interventional medicine and extraordinary talent and dedication in both research and clinical endeavors. Dr. Leon is the Founder of CRF and Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Both serve as Co-Directors of the Medical Research and Education Division at CRF.

"We are proud to honor Dr. Topol with the TCT 2011 Career Achievement Award," said Dr. Stone. "As a clinical trialist and educator, Dr. Topol has set the benchmark to which we all aspire. His ground-breaking research in acute myocardial infarction and interventional pharmacology has directly benefitted millions of patients with cardiovascular disease. And now, his singular devotion to cardiovascular genomics promises to open a window to novel approaches for the prevention and treatment of heart disease."

"Dr. Topol's current work in personalized medicine and digital technology positions him as a leader in the movement to modernize medical treatment - creating new, more effective ways to treat patients," Dr. Leon added. "His ground-breaking research in cardiology and genomics has provided more treatment and prevention options for patients and transformed our understanding of how genetics can determine a person's risk of heart disease."

Dr. Topol is currently a Professor of Genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health in La Jolla, California. He also leads the flagship NIH supported Scripps Translational Science Institute and is a co-Founder and the Vice-Chairman of the West Wireless Health Institute.

Previously, Dr. Topol served as Chair of the Department of Cardiovascular Medicine at the Cleveland Clinic, where his cardiovascular program was ranked by U.S. News & World Report as number one in the nation in patient care and research for 12 years. His upcoming book, The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care, which addresses the convergence of the digital revolution and medicine, will be released in January 2012.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Connor Sport Court Lays the Ground for NBA All-Star Jam Session Presented by Adidas
2. Digital Signatures Presented at Electronic Document Management Conference
3. Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda
4. Game Ready(R) Presented with Frost & Sullivan 2010 Product Differentiation Excellence Award
5. New Data from Caldolor(R) Study in Burn Patients to be Presented at 42nd Annual Meeting of The American Burn Association
6. Nine Healthcare Companies Named Finalists for Innovations in HealthcareSM ABBY Awards, to be Presented April 28th
7. Zimmer Receives Recognition for Health Economics Data Presented at 77th Annual American Academy of Orthopaedic Surgeons Meeting
8. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
9. The Arnold Palmer Invitational Presented by MasterCard Expands Relationship with MasterCard to Offer Exclusive Prepaid Business Gift Cards
10. Seat Belt Champion Award Presented to Florida Legislators
11. OTC Perspectives Announces 2010 Ad Awards Finalists Presented by HealthCentral
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... Valencia, Calif. (PRWEB) , ... July 19, 2017 , ... ... has acquired the Minnesota based Health IT business unit of Constellation Inc., a move ... an already established base of operations in St. Louis, the acquisition is expected to ...
(Date:7/20/2017)... California (PRWEB) , ... July 19, 2017 , ... A ... that most successful weight loss surgery patients who had received a body contouring procedure ... health and beauty clinic Beverly Hills Physicians (BHP), which provides both types of procedures, ...
(Date:7/20/2017)... ... ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming children’s stories. “Lucky the ... Bieniek Jr. was born in Toledo, Ohio. He attended Woodward High School. He ... married to a brilliant woman with a caring heart named Tiina, who is a hospice ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov and the ... You Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. ... “Final Rule for Clinical Trials Registration and Results Information,” is a head-scratcher. After ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, ... "Due to menopause, I have frequent hot flashes, and I suffer from anxiety and ... way to keep cool while out and about." INSTA-FAN meets that need. , This ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Corp., also known as ,The Epigenetics Company, announced today the release of ... using the myDNAge ™ test. Based on Horvath,s Clock, so named ... biostatistics at the David Geffen School of Medicine at UCLA ... ™ technology is used to analyze DNA methylation patterns of over ... Epigenetic ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... TRIANGLE PARK, N.C. , July 10, 2017 /PRNewswire/ ... a $5m Convertible Note to support the development of ... by Tencent Holdings Limited, a leading Chinese Internet services ... This funding will advance multiple infectious disease product programs ... Founded by Dr. ...
Breaking Medicine Technology: